Cargando…
ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators
N6-Methyladenosine (m6A) imbalance is an important factor in the occurrence and development of prostate cancer (PCa). Many m6A regulators have been found to be significantly dysregulated in PCa. ELAVL1 is an m6A binding protein that can promote the occurrence and development of tumors in an m6A-depe...
Autores principales: | Cai, Zhonglin, Xu, Huan, Bai, Gang, Hu, Hanjing, Wang, Di, Li, Hongjun, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376624/ https://www.ncbi.nlm.nih.gov/pubmed/35978821 http://dx.doi.org/10.3389/fonc.2022.939784 |
Ejemplares similares
-
m(6)A-Mediated Biogenesis of circDDIT4 Inhibits Prostate Cancer Progression by Sequestrating ELAVL1/HuR
por: Kong, Zhe, et al.
Publicado: (2023) -
Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipid Remodeling
por: Li, Huiying, et al.
Publicado: (2020) -
MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022) -
Data on isoaspartylation of neuronal ELAVL proteins
por: Pulido, Mario A., et al.
Publicado: (2016) -
HuR (Elavl1) and HuB (Elavl2) Stabilize Matrix Metalloproteinase-9 mRNA During Seizure-Induced Mmp-9 Expression in Neurons
por: Zybura-Broda, Katarzyna, et al.
Publicado: (2018)